Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 589 of 5804
-
Can a phone app ease social anxiety? new study investigates
Symptom relief TerminatedThe investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for social anxiety disorder (SAD). The investigators hypothesize that participants receiving app-CBT will have greater reduction in LSAS scores than those in the waitli…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Talk to your computer: could a chatbot detect Alzheimer's before you forget?
Diagnosis ENROLLING_BY_INVITATIONEarly cognitive disorders diagnosis is becoming increasingly important due to population aging. The most common causes include Alzheimer's disease and frontotemporal dementia. These diseases are also manifested by changes in speech. NLP allows us to identify and classify these ch…
Phase: NA • Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New hope for tough lymphomas: balstilimab trial opens
Disease control Recruiting nowThe goal of this study is to see if the drug balstilimab is safe and effective in participants with relapsed/refractory lymphomas. Participants will receive balstilimab every 3 weeks and their outcomes will be assessed periodically.
Phase: PHASE2 • Sponsor: Immune Oncology Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Nerve block or talk therapy may prevent chronic pain in PTSD patients
Disease control Recruiting nowAlthough most people recover from acute pain (such as pain caused by injury, surgery, repetitive motion, or unknown causes), many people do not fully recover and will experience chronic pain. Untreated posttraumatic stress disorder (PTSD) appears to be a key risk factor for the t…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Modified immune cells aim to make stem cell transplants safer
Disease control Recruiting nowIn this clinical trial, the investigators aim to apply CD62L depleted donor lymphocyte infusion (DLI) together with in vitro T cell depleted haploidentical hematopoietic stem cell transplantation (HSCT) to treat patients with malignant or non-malignant disease in need of HSCT. Th…
Phase: PHASE2 • Sponsor: Hong Kong Children's Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:20 UTC
-
Can a classroom tool ease teen anxiety and depression? new study aims to find out.
Symptom relief OngoingAdolescence is a developmental period of significant risk for anxiety, depressive symptoms, and suicidality, and the investigators propose to target key peer-based risk and protective factors using Cooperative Learning (CL). CL is a small-group instructional approach that can enh…
Phase: NA • Sponsor: University of Oregon • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Two-Drug cocktail shows promise for awakening traumatic brain injury patients
Disease control CompletedThe goal of this interventional study is to Measure the potential benefits of combined administration of cerebrolysin and amantadine sulfate as an add-on therapy to the standard management of patients admitted to the ICU with traumatic brain injury.
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThrough the neoadjuvant treatment with a combination of Cadonilimab and Lenvatinib, it enabled the successful and safe implementation of partial nephrectomy in patients with localized renal cancer, who had indications for nephron-sparing surgery but faced considerable difficulty …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a 1-Month pill course stop TB in schools?
Disease control Recruiting nowThis is a prospective, multi-center, open-label, cluster randomized controlled clinical trial conducted in school settings to estimate the non-inferiority effect of 1H3P3 compared with 3HR.
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New CAR t cell therapy targets Tough-to-Treat leukemia
Disease control Recruiting nowThe purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe, and to look for the highest dose of CD371-YSNVZ-IL18 CAR T cells that cause few or mild side effects in participants.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail of drugs shows promise for Hard-to-Treat throat cancer
Disease control OngoingFirst-diagnosed metastasis or recurrence/metastasis NPC Patients will be treated with anlotinib, penpulimab and capecitabine.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Personalized cell therapy takes on childhood cancers
Disease control Recruiting nowThis is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New immune therapy aims to keep head and neck cancer at bay
Disease control Recruiting nowHead and neck cancer is the malignant tumor with the highest morbidity and mortality, of which 60% present with locally advanced disease at initial diagnosis, and the 5-year survival rate of standard treatment is less than 30%. Standard of care (SOC) including adjuvant and neoadj…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could simple changes prevent early stillbirth? new study investigates
Knowledge-focused Recruiting nowThis project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision. The death of a child before birth (also called stillbirth or miscarriage) has enduring psy…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Magic mushroom therapy slashes heavy drinking in new trial
Disease control CompletedNote: The trial is only eligible for citizens of Denmark. The purpose of this project is to assess the treatment efficacy of a single high dose of psilocybin administered within a protocol of psychological support to patients diagnosed with alcohol use disorder (AUD).
Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New chemo spray shows promise for Hard-to-Treat abdominal cancers
Disease control Recruiting nowPressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel minimally invasive drug delivery system for patients with peritoneal metastases (PM). It has been considered as a safe and feasible palliative treatment alternative proven by previous phase I studies. Currently a…
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a simple therapy delivered by phone or app prevent suicide in older adults?
Prevention Recruiting nowSuicide represents a personal tragedy and an enormous global public health problem. One of the most vulnerable groups is adults 50 years and older. Despite this stage of life is particularly amenable to the implementation of targeted suicide prevention strategies, we have few stu…
Phase: NA • Sponsor: University of Santiago de Compostela • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New hope for PBC patients: drug aims to slow liver damage
Disease control Recruiting nowThe participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive disease, characterised by damage to the bile ducts in the liver, leading to a build-up of bile acids which causes further damag…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug bitopertin offers hope for sunlight pain relief in rare blood disorders
Disease control ENROLLING_BY_INVITATIONThis is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
Phase: PHASE2, PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo targets tough pancreatic cancer in early trial
Disease control OngoingThis study is an open-label, multicentre, Phase 1b trial designed to determine the safety, tolerability, efficacy, PK, pharmacodynamics (PD) and proof-of-concept of OMO-103 in combination with the standard regimen gemcitabine/nab-paclitaxel in patients with metastatic pancreatic …
Phase: PHASE1 • Sponsor: Peptomyc S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC